431 related articles for article (PubMed ID: 17240485)
1. New meningococcal C polysaccharide-tetanus toxoid conjugate Physico-chemical and immunological characterization.
Cuello M; Cabrera O; Martinez I; Del Campo JM; Camaraza MA; Sotolongo F; Pérez O; Sierra G
Vaccine; 2007 Feb; 25(10):1798-805. PubMed ID: 17240485
[TBL] [Abstract][Full Text] [Related]
2. Memory immune response generated in Cercopithecus aethiops against meningococcal polysaccharide serogroup C conjugate vaccine.
Carmenate T; Guirola M; Alvarez A; Canaán L; González S; Caballero E; Menéndez T; Guillén G
FEMS Immunol Med Microbiol; 2005 Feb; 43(2):133-40. PubMed ID: 15681142
[TBL] [Abstract][Full Text] [Related]
3. Preparation and characterization of an immunogenic meningococcal group A conjugate vaccine for use in Africa.
Lee CH; Kuo WC; Beri S; Kapre S; Joshi JS; Bouveret N; LaForce FM; Frasch CE
Vaccine; 2009 Jan; 27(5):726-32. PubMed ID: 19063929
[TBL] [Abstract][Full Text] [Related]
4. Moderate PEGylation of the carrier protein improves the polysaccharide-specific immunogenicity of meningococcal group A polysaccharide conjugate vaccine.
Zhang T; Yu W; Wang Y; Hu T
Vaccine; 2015 Jun; 33(28):3208-14. PubMed ID: 25964170
[TBL] [Abstract][Full Text] [Related]
5. Comparison of Neisseria meningitidis serogroup W135 polysaccharide-tetanus toxoid conjugate vaccines made by periodate activation of O-acetylated, non-O-acetylated and chemically de-O-acetylated polysaccharide.
Gudlavalleti SK; Lee CH; Norris SE; Paul-Satyaseela M; Vann WF; Frasch CE
Vaccine; 2007 Nov; 25(46):7972-80. PubMed ID: 17936445
[TBL] [Abstract][Full Text] [Related]
6. Effect of conjugation methodology on the immunogenicity and protective efficacy of meningococcal group C polysaccharide-P64k protein conjugates.
Carmenate T; Canaán L; Alvarez A; Delgado M; González S; Menéndez T; Rodés L; Guillén G
FEMS Immunol Med Microbiol; 2004 Apr; 40(3):193-9. PubMed ID: 15039094
[TBL] [Abstract][Full Text] [Related]
7. Induction of meningococcal group B polysaccharide-specific IgG antibodies in mice by using an N-propionylated B polysaccharide-tetanus toxoid conjugate vaccine.
Jennings HJ; Roy R; Gamian A
J Immunol; 1986 Sep; 137(5):1708-13. PubMed ID: 3091688
[TBL] [Abstract][Full Text] [Related]
8. Effects of prior polysaccharide vaccination on magnitude, duration, and quality of immune responses to and safety profile of a meningococcal serogroup C tetanus toxoid conjugate vaccination in adults.
Southern J; Deane S; Ashton L; Borrow R; Goldblatt D; Andrews N; Balmer P; Morris R; Kroll JS; Miller E
Clin Diagn Lab Immunol; 2004 Nov; 11(6):1100-4. PubMed ID: 15539513
[TBL] [Abstract][Full Text] [Related]
9. Characteristics of two types of meningococcal group C polysaccharide conjugates using tetanus toxoid as carrier protein.
Beuvery EC; Roy R; Kanhai V; Jennings HJ
Dev Biol Stand; 1986; 65():197-204. PubMed ID: 3104115
[TBL] [Abstract][Full Text] [Related]
10. Characterization and immunogenicity of meningococcal group C conjugate vaccine prepared using hydrazide-activated tetanus toxoid.
Silveira IA; Bastos RC; Neto MS; Laranjeira AP; Assis EF; Fernandes SA; Leal ML; Silva WC; Lee CH; Frasch CE; Peralta JM; Jessouroun E
Vaccine; 2007 Oct; 25(41):7261-70. PubMed ID: 17719147
[TBL] [Abstract][Full Text] [Related]
11. Conjugation of β-glucan markedly increase the immunogencity of meningococcal group Y polysaccharide conjugate vaccine.
Qiao W; Ji S; Zhao Y; Hu T
Vaccine; 2015 Apr; 33(17):2066-72. PubMed ID: 25728319
[TBL] [Abstract][Full Text] [Related]
12. Adjuvant can improve protection induced by OMV vaccine against Neisseria meningitidis serogroups B/C in neonatal mice.
Fukasawa LO; Dias WO; Schenkman RP; Raw I; Tanizaki MM
FEMS Immunol Med Microbiol; 2004 Jul; 41(3):205-10. PubMed ID: 15196569
[TBL] [Abstract][Full Text] [Related]
13. Gamma 3 gene-disrupted mice selectively deficient in the dominant IgG subclass made to bacterial polysaccharides undergo normal isotype switching after immunization with polysaccharide-protein conjugate vaccines.
Shapiro DA; Threadgill DS; Copfer MJ; Corey DA; McCool TL; McCormick LL; Magnuson TR; Greenspan NS; Schreiber JR
J Immunol; 1998 Oct; 161(7):3393-9. PubMed ID: 9759856
[TBL] [Abstract][Full Text] [Related]
14. Murine immune responses to Neisseria meningitidis group C capsular polysaccharide and a thymus-dependent toxoid conjugate vaccine.
Rubinstein LJ; García-Ojeda PA; Michon F; Jennings HJ; Stein KE
Infect Immun; 1998 Nov; 66(11):5450-6. PubMed ID: 9784556
[TBL] [Abstract][Full Text] [Related]
15. Analytical, toxicological and immunological consequences of the use of N-ethyl-N'-(3-dimethylaminopropyl) carbodiimide as coupling reagent for the preparation of meningococcal group C polysaccharide-tetanus toxoid conjugate as vaccine for human use.
Beuvery EC; Speijers GJ; Lutz BI; Freudenthal D; Kanhai V; Haagmans B; Derks HJ
Dev Biol Stand; 1986; 63():117-28. PubMed ID: 3091432
[TBL] [Abstract][Full Text] [Related]
16. Immunochemistry of groups A, B, and C meningococcal polysaccharide-tetanus toxoid conjugates.
Jennings HJ; Lugowski C
J Immunol; 1981 Sep; 127(3):1011-8. PubMed ID: 6790606
[TBL] [Abstract][Full Text] [Related]
17. Mucosal immune responses to meningococcal C polysaccharide-protein conjugate in mice.
Cuello M; Cabrera O; del Campo JM; Parajón E; Sotolongo F; Camaraza MA; Arnet A; Suárez M; Pérez O
Vaccine; 2006 Apr; 24 Suppl 2():S2-72-3. PubMed ID: 16823934
[TBL] [Abstract][Full Text] [Related]
18. A novel combined Haemophilus influenzae type b-Neisseria meningitidis serogroups C and Y-tetanus-toxoid conjugate vaccine is immunogenic and induces immune memory when co-administered with DTPa-HBV-IPV and conjugate pneumococcal vaccines in infants.
Nolan T; Lambert S; Roberton D; Marshall H; Richmond P; Streeton C; Poolman J; Boutriau D
Vaccine; 2007 Dec; 25(51):8487-99. PubMed ID: 17996996
[TBL] [Abstract][Full Text] [Related]
19. Two different methods result in the selection of peptides that induce a protective antibody response to Neisseria meningitidis serogroup C.
Prinz DM; Smithson SL; Westerink MA
J Immunol Methods; 2004 Feb; 285(1):1-14. PubMed ID: 14871530
[TBL] [Abstract][Full Text] [Related]
20. Antibody responses to meningococcal (groups A, C, Y and W135) polysaccharide diphtheria toxoid conjugate vaccine in children who previously received meningococcal C conjugate vaccine.
El Bashir H; Heath PT; Papa T; Ruggeberg JU; Johnson N; Sinha R; Balfour G; Booy R
Vaccine; 2006 Mar; 24(14):2544-9. PubMed ID: 16417952
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]